Bacteriocin nanoconjugates: boon to medical and food industry
Authors:
Open Access
- 24 December 2020
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Applied Microbiology
- Vol. 131 (3) , 1056-1071
Abstract
Resistance to antibiotics is an ongoing problem in the biomedical industry. Developing active, alternative drug therapies would reduce our reliance on antibiotics that induce resistance in micro‐organisms. To date, bacteriocins and antimicrobial peptides have shown a positive outcome as antibiotic substitutes and synergists apart from phage therapy, antibodies and probiotics. Bacteriocins are proteinaceous antimicrobial peptides synthesized by lactic acid bacteria extensively used as bio‐preservatives and alternative to traditional antibiotics to overcome the problem of drug‐resistant pathogens. Nonetheless, the use of bacteriocins has several limitations such as limited antimicrobial spectrum, requiring high dose, sensitivity to proteolytic enzymes, etc. Nanoparticles are one of the promising area of research explored to improve antimicrobial spectrum of bacteriocins. This review therefore highlights the recent developments and research pertaining to use of nanoparticles and bacteriocin conjugates to tackle the resistance crisis as well as its applications in food industry.Keywords
This publication has 79 references indexed in Scilit:
- Fragments of the Bacterial Toxin Microcin B17 as Gyrase PoisonsPLOS ONE, 2013
- Liposome: classification, preparation, and applicationsDiscover Nano, 2013
- Nisin, an apoptogenic bacteriocin and food preservative, attenuates HNSCC tumorigenesis via CHAC1Cancer Medicine, 2012
- Release of Bacteriocins from Nanofibers Prepared with Combinations of Poly(D,L-lactide) (PDLLA) and Poly(Ethylene Oxide) (PEO)International Journal of Molecular Sciences, 2011
- Designing carbohydrate nanoparticles for prolonged efficacy of antimicrobial peptideJournal of Controlled Release, 2011
- Carbohydrate nanoparticle‐mediated colloidal assembly for prolonged efficacy of bacteriocin against food pathogenBiotechnology and Bioengineering, 2011
- Peptide-Lipid Huge Toroidal Pore, a New Antimicrobial Mechanism Mediated by a Lactococcal Bacteriocin, Lacticin QAntimicrobial Agents and Chemotherapy, 2009
- Multidrug Resistance in BacteriaAnnual Review of Biochemistry, 2009
- Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to ClinicCritical Reviews™ in Therapeutic Drug Carrier Systems, 2009
- Sequence-specific recognition of colicin E5, a tRNA-targeting ribonucleaseNucleic Acids Research, 2006